Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ISIS-23722 selected for clinical development

April 24, 2003

Initiation of phase I/II study of CG-7870 plus radiation in early-stage prostate cancer

April 24, 2003

Diatos licenses European rights for Super-Leu-Dox

April 24, 2003

Novel modulators of LPA receptors and their use in cancer, wound healing, etc.

April 24, 2003

Aventis scientists identify novel protein kinase inhibitors

April 24, 2003

Novel tyrosine kinase inhibitors under study at Merck & Co.

April 24, 2003

Three series of antitumor agents prepared and tested at Synta

April 24, 2003

AGI Dermatics regains rights to Dimericine

April 23, 2003

Phase II studies of ILX-651 planned

April 23, 2003

Northwest Biotherapeutics receives NCI grant for tumor growth inhibition

April 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...